Stage 2 breakouts and relative-strength leaders tell you when. Forensic quality checks — cash flow vs profit, pledging, promoter behaviour — tell you what deserves your money. AlphaStage is the first Indian stock platform that ships both, with every claim sourced and dated.
No invented user counts. No fake star ratings. If a number appears on this site, it links to where it came from.
Most tools stop at timing. We added the step that separates a trade from a blow-up.
Institutional money moves sector-first. Week-over-week relative-strength movers and an RRG-style rotation map show which industries are entering leadership — before individual charts make it obvious.
IBD-style RS percentiles (0–100, quarterly-weighted) across the full NSE universe — versus the market and versus the stock's own sector. Leaders score 80+. Everything else is noise.
Weinstein stage classification on weekly charts: price above a rising 30-week MA, breakout from a base on ≥2× volume, rising RS line. Only a small minority of stocks qualify at any time — that scarcity is the point.
Before a stock earns a PASS: 5-year cash-flow-vs-profit, pledging, promoter buying/selling, working-capital trends, PE vs its own history, auditor & SEBI red-flag sweep. A beautiful P&L with 46% cash conversion is a trap — this layer catches it.
Free tools can list "Stage 2 stocks". Paid tools can rank momentum. What nobody ships is the audit: is the profit cash-backed? Is the promoter pledging while selling? Did the multiple re-rate above its own decade band? We publish the checks, the sources and the dates — so you can re-verify every line.
| Check | Typical screener | AlphaStage |
|---|---|---|
| Stage 2 / RS momentum | ✓ | ✓ |
| Sector rotation map | some | ✓ |
| Cash-flow vs profit (5 yr) | ✗ | ✓ per stock |
| Pledging & promoter deals | ✗ | ✓ incl. fresh filings |
| PE vs own 10-yr band | ✗ | ✓ |
| Verdicts with sources & dates | ✗ | ✓ every claim |
| Exit discipline (Stage 3 warnings) | ✗ | ✓ in method |
The full Nifty 500 classified into Stage 1–4 from real end-of-day prices: stage entry date, weeks in stage, RS percentile, distance from the 52-week high and 13-week return. Filter by industry, stage and RS; export to CSV.
Open ↗The forensic layer: PASS / CAUTION / FAIL verdicts with the exact reason and source for each.
Open ↗RRG-style quadrants — Leading, Improving, Weakening, Lagging — plus industry RS movers week over week.
Risk-first sizing: capital, risk %, entry, stop → exact quantity. The tool that makes stops real.
Star any stock on any screen — it stays on your device, no account needed.
Weinstein's four stages with exact rules, RS mathematics, the 3-filter quality framework and the 16-point forensic checklist — written out completely. No "book a call to learn the secret".
Daily Stage 2 & RS screens · sector rotation · quality verdicts · exports
Preview screens ↗Reference points: WealthLab ₹600/mo · ₹4,999/yr — MarketSmith India ₹13,900/yr — Trendlyne ~₹2,090/yr. AlphaStage launch pricing undercuts the direct comparable while adding the forensic layer.
Stan Weinstein's framework classifies every stock into four stages: basing (1), advancing (2), topping (3) and declining (4), using weekly charts and the 30-week moving average. The rule is brutal and simple — only buy Stage 2, and exit when Stage 3 behaviour appears. The full rules are on our Learn page, free.
Free tools can list momentum candidates. They don't tell you the company's operating cash flow ran at 46% of reported profit for five years, or that the promoter pledged 11% of the company the same month they sold ₹1,000 Cr of stock. Our quality layer does — with sources and dates you can check yourself.
No. AlphaStage is a data and research tool. It is not SEBI-registered and does not give buy/sell recommendations. Verdicts like PASS or FAIL describe data quality against a published checklist — what you do with them is your decision.
Exchange end-of-day prices, company filings, screener.in consolidated financials and primary-source news — each table states its snapshot date, and forensic claims link to the filing or article they came from. If a number has no source, we don't publish it.
No — and we won't claim numbers we can't show you. This platform is new. The methodology pages, the checklists and the sourced verdicts are the proof of work; judge us on those.